SEATTLE — Stratos Genomics, Inc., a 4th generation DNA sequencing technology company, today announced it has raised $20 million in venture capital from Fisk Ventures. The funds will be used for final system development leading to commercial introduction of the company’s proprietary sequencing platform. The next phase of system development will build upon recent breakthroughs in Stratos […]
Woburn, MA: Quad Technologies, a visionary innovator in cell and gene therapy bioprocessing, today announced a strategic partnership with Sartorius Stedim Biotech, a leading provider of cutting-edge products and services for the biopharmaceutical industry. This partnership will enable worldwide availability of a magnetic bead-free T cell activation product built with Quad Technologies’ patented QuickGel® platform. […]
CARLSBAD, Calif. — Thermo Fisher Scientific today announced the Ion GeneStudio S5 Series, a new line of bench top next-generation sequencing (NGS) instruments that provides unmatched flexibility and scalability enabled by five Ion S5 chips, including the new Ion 550 chip, to facilitate wide-ranging experiments on a single platform. The new series also provides low cost per sample […]
–Collaboration will be a new service offering for Berry Genomics and entry point for 10x Genomics into the NIPT Market in China– PLEASANTON, Calif. & BEIJING–10x Genomics, Inc., a company focused on accelerating genomic discovery, and Berry Genomics Co. Ltd (SZSE:000710), a company devoted to developing and offering genomic solutions for genetic diseases, today announced […]
— MGI’s BGISEQ-500RS Genetic Sequencer, Forthcoming MGISEQ Genetic Sequencers Compatible with 10x Genomics Solutions— PLEASANTON, Calif. & SHENZHEN, China–10x Genomics, Inc. and MGI, a subsidiary of BGI, today announced that the BGISEQ-500RS genetic sequencer has met the rigorous standards of the new 10x Genomics Compatible Program. MGI will also ensure that the MGISEQ series genetic […]
Highlights: • Focused R&D expansion providing core competencies in biosensor chemistries and bioassay solutions targeting pharma/biopharma applications for near and long-term portfolio expansion • Broadens cell analysis portfolio with addition of complementary plate reader-based cellular assays • Accelerates expansion into pharma/biopharma discovery and in vitro toxicology screening applications SANTA CLARA, Calif. Agilent Technologies Inc. (NYSE: A) today announced […]
Industry-Leading Sequencing Technology for Under $20K SAN DIEGO–Illumina, Inc. (NASDAQ: ILMN) announced today the launch of the iSeqTM 100 Sequencing System. The new, next-generation sequencing (NGS) system delivers exceptional data accuracy, at a low capital cost, making Illumina technology available to virtually any lab. The combination of the company’s proven sequencing by synthesis (SBS) chemistry, along with the complementary […]
Industry-leading amplicon solution facilitates targeted next-generation sequencing in multiple application areas CARLSBAD, Calif. & SAN DIEGO–Thermo Fisher Scientific and Illumina, Inc. (NASDAQ: ILMN) today announced they have signed a commercial agreement that enables Illumina to sell Ion AmpliSeq technology to researchers who conduct scientific studies on Illumina’s next-generation sequencing (NGS) platforms. The best-in-class amplicon technology is highly effective in capturing DNA and […]
Goal set to exceed $140 million of NGS-related sales in 2018, up from over $115 million in 2017 New Enterprise Genomics Services to offer gene panel customization capabilities to customers GeneReader NGS System plans include enhanced chemistry, more powerful gene panels Hilden, Germany, and Germantown, Maryland, January 8, 2018 – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt […]
Companies Target Review Aimed at Molecular Oncology and Hereditary Diseases SAN DIEGO–Illumina, Inc. (NASDAQ: ILMN) and KingMed Diagnostics (SSE: 603882.SS) today announced an agreement to jointly develop novel oncology and hereditary disease testing applications utilizing Illumina’s next-generation sequencing (NGS) technology. The collaboration is a significant step toward China Food and Drug Administration (CFDA) review and approval, and serves as a […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
